- Neutra
is expanding its presence in the CBD market, which is now projected to
reach $20 billion by 2024
- The
majority of CBD product sales are expected to soon occur in general retail
stores and online instead of at cannabis dispensaries
- Neutra’s
acquisition of VIVIS adds an emerging retail brand of hemp-based health
and nutritional products to the company’s portfolio
- Its
acquisition of J3 Holdings includes land, a warehouse and licensing to
cultivate hemp and refine it into usable forms
Neutra Corp. (OTCQB: NTRR), an early stage research and
development company focusing on modern healthy living solutions, has astutely
taken advantage of several opportunities as the nation’s exploding CBD market
begins to move into the general market retail sector. Two recent acquisitions
are expected to accelerate Neutra’s corporate vision of bringing the highest
quality, high potency hemp-based CBD extract products to retail customers.
Neutra’s purchase of VIVIS, an emerging retail brand of
hemp-based health and nutritional products, is underway with the signing of a
letter of intent (LOI) (http://ibn.fm/VFex6).
“This acquisition will give Neutra Corp. an even stronger
market presence with an established brand already recognized for superiority,”
Neutra President and CEO Sydney Jim stated in a news release. “VIVIS’
hemp-derived CBD (cannabidiol) products are third-party certified as
containment-free and of consistent quality and potency. Consumers are
increasingly looking for this certification when they buy hemp-based CBD
products. With VIVIS as the new retail face of Neutra, we’re expecting greater interest
in the other products we’re bringing to market.”
Leading cannabis researchers BDS Analytics and Arcview
Market Research project that the collective market for CBD sales in the U.S.
will surpass $20 billion by 2024, achieving a compound annual growth rate of 49
percent across all distribution channels (http://ibn.fm/Gq1Vc). Interestingly, the report predicts
that the majority of CBD product sales will soon occur in general retail stores
instead of cannabis dispensaries, as Forbes reported (http://ibn.fm/uee8p). National
chains like CVS and Walgreens have announced plans to carry CBD products in
some stores, and these offerings are already in several department stores, such
as Sephora (http://ibn.fm/3bLqe).
VIVIS is already selling a carefully formulated product that
utilizes a 99 percent or higher grade of hemp-extracted crystalline CBD. Each
product sold by VIVIS is third-party lab tested for purity and receives a
certificate of analysis verifying that it has been produced with the most
potent and contaminant-free hemp-extracted CBD (http://ibn.fm/ztpDL).
Neutra’s acquisition of J3 Holdings, which currently owns
land, a warehouse and licensing to cultivate hemp and refine it into useable
forms, will provide the company with numerous options as it develops into a
vertically integrated CBD company, according to a news release (http://ibn.fm/AzLyu).
“This is a big acquisition and a great demonstration of the
continued evolution of our company,” Jim added. “This shows we’re moving
forward with our plans to become a serious player in the ever-growing CBD
market. CBD products are rapidly gaining mainstream acceptance.”
For more information, visit the company’s website at www.NeutraInc.com
NOTE TO INVESTORS: The latest news and updates
relating to NTRR are available in the company’s newsroom at http://ibn.fm/NTRR
About QualityStocks
QualityStocks is
committed to connecting subscribers with companies that have huge potential to
succeed in the short and long-term future. It is part of our mission statement
to help the investment community discover emerging companies that offer
excellent growth potential. We offer several ways for investors to learn more
about investing in these companies as well as find and evaluate them.
QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com
Please see full terms of use and disclaimers on the
QualityStocks website applicable to all content provided by QS, wherever
published or re-republished: http://www.qualitystocks.net/disclaimer.php
No comments:
Post a Comment